article thumbnail

Global contrast media shortage means urgent changes in interventional radiology practices

Scienmag

GE Healthcare, the manufacturer, had to shut its plant in Shanghai, China, due to local COVID policies, disrupting 80% of their production. […].

article thumbnail

How GE HealthCare’s SIGNA MAGNUS 3.0T Transforms Neuroimaging

XTalks

XTALKS WEBINAR: Unlock Growth in Medical Device Manufacturing with an AI-Powered eQMS Live and On-Demand: Monday, December 9, 2024, at 11am EST (4pm GMT/UK) Register for this free webinar to unlock the potential of AI in quality management and propel medical device manufacturing into the future.

Radiology 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Publishes Final Rule to Amend and Reduce Regulatory Burden on Outdated and Duplicative Requirements as They Pertain to Radiological Health Regulations

FDA Law Blog

Mullen — Sections of the radiological health regulations have been updated with the goal of lessening regulatory burdens. has been modified so that manufacturers of diagnostic x-ray products no longer need to submit initial (§ 1002.10), supplemental (§§ 1002.11), abbreviated (§ 1002.12) and annual reports (§ 1002.13).

article thumbnail

Merit Medical to Participate at Four Conferences in September

BioTech 365

NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, … Continue reading → SOUTH JORDAN, Utah, Sept.

article thumbnail

MIOTIFY platform for digital health products clears AZ road test

pharmaphorum

“When a manufacturer uses an algorithm to transform input data and interpret the output in a way that will be used to inform a clinical decision, it becomes classified as SaMD and is therefore regulated,” according to MIOTIFY’s founder Sheena Macpherson. Sheena Macpherson.

article thumbnail

“Get the First Inch Right”: Oncology Combination Product First-in-class Treatment Success Story

Camargo

Using a patient-centered drug development approach , Camargo provided the critical strategic regulatory and commercial insights and supported the product development; regulatory strategy (including key regulatory FDA meetings); nonclinical work; chemistry, manufacturing and controls (CMC) work; and electronic submissions.

article thumbnail

Advancing and Safeguarding Clinical Research for a Better Tomorrow

Advarra

Over the years, Advarra has reviewed a wide range of clinical research studies and worked every day alongside leading pharmaceutical manufacturers, medical researchers, and healthcare institutions. Without clinical research, these medical breakthroughs would remain out of reach for patients.